Clinical trial
A Phase II Randomized Study of Induction Chemotherapy Followed by Concurrent Chemo-radiotherapy in Locally Advanced Pancreatic Cancer
NCT01867892 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomized Study of Induction Chemotherapy Followed by Concurrent Chemo-radiotherapy in Locally Advanced Pancreatic Cancer
- Lead sponsor
- National Health Research Institutes, Taiwan
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2013
- Completion date
- May 31, 2019
- Enrollment
- 86 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancer